ATRC logo

ATRC
Atricure Inc

388
Mkt Cap
$2.06B
Volume
340,236.00
52W High
$43.11
52W Low
$28.29
PE Ratio
-68.16
ATRC Fundamentals
Price
$41.77
Prev Close
$41.44
Open
$41.50
50D MA
$37.12
Beta
1.06
Avg. Volume
481,983.45
EPS (Annual)
-$0.9517
P/B
4.32
Rev/Employee
$357,928.46
Loading...
Loading...
News
all
press releases
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OSUR files FDA applications seeking approval for two at-home STI tests, advancing decentralized diagnostics; shares gain 3.8% as it targets long-term growth.
Zacks·1d ago
News Placeholder
More News
News Placeholder
AtriCure (NASDAQ:ATRC) Share Price Crosses Above 200-Day Moving Average - Should You Sell?
AtriCure (NASDAQ:ATRC) Shares Cross Above 200 Day Moving Average - What's Next...
MarketBeat·2d ago
News Placeholder
Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA
OMER wins FDA approval for YARTEMLEA, the first TA-TMA therapy, marking its first commercial product and a shift to revenue generation.
Zacks·9d ago
News Placeholder
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Moderate Buy" from Brokerages
AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven ratings firms that are covering the stock, Marketbeat.com reports. One...
MarketBeat·14d ago
News Placeholder
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have been given an average rating of "Moderate Buy" by the eleven brokerages that are covering the firm, Marketbeat.com reports. One research...
MarketBeat·14d ago
News Placeholder
Has AtriCure (ATRC) Outpaced Other Medical Stocks This Year?
Here is how AtriCure (ATRC) and Ensign Group (ENSG) have performed compared to their sector so far this year.
Zacks·14d ago
News Placeholder
AtriCure (NASDAQ:ATRC) Stock Crosses Above Two Hundred Day Moving Average - Here's Why
AtriCure (NASDAQ:ATRC) Stock Crosses Above Two Hundred Day Moving Average - What's Next...
MarketBeat·15d ago
News Placeholder
AtriCure (ATRC) Is Up 6.32% in One Week: What You Should Know
Does AtriCure (ATRC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·19d ago
News Placeholder
AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...
Business Wire·21d ago
News Placeholder
JPMorgan Chase & Co. Boosts AtriCure (NASDAQ:ATRC) Price Target to $48.00
JPMorgan Chase & Co. upped their price target on AtriCure from $42.00 to $48.00 and gave the company an "overweight" rating in a research report on Tuesday...
MarketBeat·22d ago
<
1
2
...
>

Latest ATRC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.